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Abstract
Toll-like receptors (TLRs) play a fundamental role in the immune system by detecting pathogen associated molecular
patterns (PAMPs) to sense host infection. Ethanol at doses relevant for humans inhibits the pathogen induced cytokine
response mediated through TLRs. The current study was designed to investigate the mechanisms of this effect by
determining whether ethanol inhibits TLR3 and TLR4 mediated TNF-a secretion through inhibition of transcription factor
activation or post-transcriptional effects. In NF-kB reporter mice, activation of NF-kB in vivo by LPS was inhibited by ethanol
(LPS alone yielded 170,000635,300 arbitrary units of light emission; LPS plus ethanol yielded 56,120616880, p=0.04).
Inhibition of protein synthesis by cycloheximide revealed that poly I:C- or LPS-induced secreted TNF-a is synthesized de
novo, not released from cellular stores. Using real time RT-PCR, we found inhibition of LPS and poly I:C induced TNF-a gene
transcription by ethanol. Using an inhibitor of tumor necrosis factor alpha converting enzyme (TACE), we found that
shedding caused by TACE is a prerequisite for TNF-a release after pathogen challenge. Flow cytometry was used to
investigate if ethanol decreases TNF-a secretion by inhibition of TACE. In cells treated with LPS, ethanol decreased both
TNF-a cell surface expression and secretion. For example, 4.6960.60% of untreated cells were positive for cell surface TNF-a,
LPS increased this to 25.1860.85%, which was inhibited by ethanol (86.8 mM) to 14.2960.39% and increased by a TACE
inhibitor to 57.8860.62%. In contrast, cells treated with poly I:C had decreased secretion of TNF-a but not cell surface
expression. There was some evidence for inhibition of TACE by ethanol in the case of LPS, but decreased TNF-a gene
expression seems to be the major mechanism of ethanol action in this system.
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Introduction
We and others have reported that ethanol, at concentrations
relevant to human exposure, inhibits signaling through toll-like
receptors [1], [2], [3], [4] and the resultant production of a wide
range of cytokines and chemokines [5]. However, it has also been
reported that ethanol administration suppresses soluble TNF-a
production at the level of translation or release of the protein [6,7].
This would imply that either TNF-a mRNA or TNF-a protein is
being stored in the cell, and available at the time of pathogen
challenge and that ethanol acts by inhibiting release rather than
production of the mRNA or protein. The release of TNF-a from
the cell membrane is dependent on TNF-a converting enzyme
TACE, and it has been reported that the function of this enzyme
at the cell surface is inhibited by ethanol [6,7]. It is known (and our
results confirm) that macrophages express TNF-a in the cell
membrane even when they are not activated, but it is not clear if
the amount is sufficient to account for a substantial portion of the
soluble TNF-a produced by these cells upon stimulation. This
laboratory has reported that ethanol inhibits TLR4 mediated
signaling and subsequent NF-kB activation and cytokine produc-
tion. Thus, there seems to be evidence supporting TACE as well as
TLR4 as targets of immunosuppressive effects of ethanol. The
study described here was designed to investigate the relative role of
these two mechanisms in the same experimental system.
The study described here focuses on TLR3 and TLR4. The
TLR4 molecule senses lipopolysaccarides (LPS) from the outer
membrane of gram-negative bacteria. The natural ligand for
TLR3 is double stranded RNA (dsRNA) of viral origin. It also
senses the synthetic dsRNA analog polyinosinic:polycytidylic acid
(poly I:C). All TLRs apart from TLR3 recruit the adapter protein
MyD88 (myeloid differentiation primary response gene 88) to the
TIR domain [8], [9], leading to signaling through NF-kBo r
MAPK to induce transcription of inflammatory cytokine genes.
However, TLR3 signaling depends on the adapter protein TRIF
(TIR-containing adaptor inducing IFN-b), [10], [11], to activate a
pathway that results in activation of the transcription factor IRF-3
(IFN-regulatory factor 3) [12] to induce type I interferons. TLR3
can also activate NF-kB or the MAPK pathway by mechanisms
that are not fully understood. Because TLR4 can recruit both
adapter proteins, MyD88 and TRIF [10], there is a signaling
pathway that is common to TLR3 and TLR4.
Tumor necrosis factor alpha (TNF-a) is a proinflammatory
cytokine and a major player in the regulation of the immune
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the immune system upon pathogen challenge. Pro-TNF-a is a
homotrimeric type II transmembrane protein [13], that is
proteolytically cleaved from the cell surface by TACE [14],
[15]. TACE, also known as A Disintegrin And Metalloproteinase
17 (ADAM17), is a type I transmembrane protein that is
constitutively expressed. Its mRNA has been found in most tissues
[14]. Human TACE cleaves the protein bond of pro-TNF-a
between the amino acids Ala-76 and Val-77 [14]. Mouse TACE
cleaves between Thr-79 and Leu-80 of the mouse precursor
TNF-a cleavage site [16]. Catalytic activity of TACE is induced
by LPS [17], [18], and downregulated by IL-10 in an early stage,
and by Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) in a
later stage. The mechanism of TACE activation is still poorly
understood. It has been reported, that phosphorylation of TACE
at Thr-735 leads to activation and protein trafficking [19], [20],
[21]. TACE is inhibited by a range of synthetic matrix
metalloproteinase (MMP) inhibitors. Its natural inhibitor is
TIMP-3 [22]. The synthetic metalloproteinase inhibitor, TNF-a
processing inhibitor-0 (TAPI-0) has been widely used in vitro
[23], [24].
Inhibition of TACE and inhibition of signaling by ethanol could
both contribute to the inhibition of the release of soluble TNF-a.
The study described here was designed to evaluate both
mechanisms in the same experimental system. The major novel
finding of this study was that inhibition of TACE by ethanol was
not the major mechanism that decreased production of soluble
TNF-a. In particular, we found that ethanol decreased both cell
surface and released TNF-a, unlike a known TACE inhibitor,
which increased cell surface TNF-a but decreased the released
form. This suggest that inhibition of signaling and TNF-a gene
expression (which were confirmed here) was a more important
mechanism of action in this experimental system.
Results
New protein synthesis is required for maximum
production of secreted TNF-alpha
The protein synthesis inhibitor cycloheximide interferes with
the translocation step at the ribosome, thereby blocking transla-
tional elongation. To test if TNF-a is available from cellular stores,
synthesis of new protein was inhibited by cycloheximide. If TNF-a
protein were available in the cell, blocking protein synthesis would
not significantly affect the amount of TNF-a measured in cell
culture supernatants after challenge with a TLR ligand.
The effects of LPS or poly I:C alone and in combination with
cycloheximide were examined. Cycloheximinde was added to
cultures of RAW264.7 cells either at the same time point as LPS or
poly I:C, or 30 min after the addition of LPS or poly I:C to the cell
culture (Figure 1). Two hours after LPS or poly I:C addition, cell
culture supernatants were harvested, and ELISA was performed.
Added to the cell culture supernatant as long as 30 min after
LPS or poly I:C, cycloheximide caused a major decrease in TNF-
a, verified by ELISA. Cycloheximide almost completely abrogated
TNF-a synthesis after challenge with TLR ligands. As a control,
cycloheximide was also incubated with the TNF-a ELISA
standard, and it was shown not to interfere with the ELISA
system. From these findings it can be inferred that de novo
synthesis of TNF-a happens after pathogen challenge, and that the
TNF-a on the cell membrane does not represent a sufficient
‘‘storage’’ form of TNF-a, which is ready for secretion upon
stimulation. Therefore, the mechanism by which ethanol decreases
TNF-a secretion after pathogen challenge must include effects
other than or in addition to preventing its release from storage.
Ethanol could act at the transcriptional or post-transcriptional
level.
Inhibition of TNF-a secretion starts at the signaling
pathway
To investigate if ethanol suppresses NF-kB signaling in vivo, we
looked at the effect of LPS alone or in combination with ethanol in
transgenic mice. The NF-kB reporter mice carry the luciferase
gene driven by an NF- kB responsive promoter. Challenge with
TLR ligands activates the NF- kB dependent pathway causing
expression of luciferase in the reporter mice which is then detected
by injecting luciferin, resulting in light emission in tissues with high
NF-kB activation. One group of mice was gavaged with ethanol
5 min before LPS injection, and one group was only injected with
LPS. A control mouse did not receive either ethanol or LPS. After
LPS injection (1.5 hr, the time of near maximal luciferase activity),
light emission was measured with the IVIS imaging system
(Figure 2).
Mice treated with LPS show significantly more NF-kB
activation than mice treated with EtOH+LPS, measured by
overall light emission in each mouse (P,0.05). These findings
corroborate the hypothesis, that EtOH inhibition is effective at the
level of NF-kB dependent signaling, and is not limited to post-
transcriptional effects.
Ethanol inhibits LPS- and poly I:C induced TNF-a gene
transcription
Ad e c r e a s ei nN F - kB activation by ethanol should be
reflected by decreased cytokine gene transcription. Therefore,
the effect of ethanol on the LPS- and poly I:C-induced TNF-a
mRNA expression was evaluated by real time RT-PCR in
RAW264.7 cells. Appropriate groups were incubated with
ethanol for 30 min, and then with LPS or poly I:C for further
Figure 1. Mouse TNF-a ELISA assay from cell culture superna-
tants. Each group contained 6 samples. Cells were treated with LPS/
poly I:C alone, with cycloheximide and LPS/poly I:C at the same time
point, or with LPS/poly I:C first and cycloheximide 30 min later. Naive,
untreated cells served as control. Bars with no shared letters are
significantly different (p,0.05).
doi:10.1371/journal.pone.0029890.g001
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isolated from cell lysates, and real time RT-PCR was preformed
(Figure 3).
A concentration of 43.4 mM EtOH and higher in the poly I:C
group, and 86.8 mM in the LPS group, significantly inhibited the
pathogen induced TNF-a mRNA expression in RAW264.7 cells
(P,0.01). It should be noted that the dosage of ethanol used in the
NF-kB reporter mice (6 g/kg) yields a peak blood ethanol
concentration of ,86 mM [25], so results from inhibition of
NF-kB activation in vivo and inhibition of TNF-a production in
vitro with ethanol at 86.8 mM reflect similar exposure. As noted in
our previous publications, 86.8 mM would represent the high end
of the concentration range that can be found in humans, but such
concentrations are not as rare as might be expected [26], [27]. In
addition, mice clear ethanol more rapidly than humans, so
obtaining similar area under the concentration vs. time curve in
mice as reported in humans requires a higher dosage and greater
peak blood ethanol concentration in mice. For example, in
humans with a mean blood ethanol concentration of 299 mg/dL,
the clearance rate was observed to be 20.4 mg/dL/hr [28]. Our
results with the mouse model used in the present study indicate
that mice with virtually the same initial blood ethanol concentra-
tion have a clearance rate of 37.18 mg/dL/hr [25] (using a dosage
of 5 g/kg). Finally, we have recently shown that TNF-a
production induced by Escherichia coli in mice is almost eliminated
by ethanol at both 4 g/kg and 6 g/kg in mice [5], and a dosage of
4 g/kg in our model yields a peak blood ethanol concentration of
,43 mM (200 mg/dL) [25], a concentration frequently observed
in binge drinkers. In the poly I:C group, the concentration of
173.6 mM EtOH was added to show the direction of the EtOH
effect, although this concentration is not relevant in humans. The
greater induction of TNF-a mRNA by LPS than poly I:C
(Figure 3) is consistent with the greater induction of TNF-a protein
by LPS than poly I:C (Figure 1). These results support the idea
that ethanol affects transcription of TNF-a in activated macro-
phages.
Figure 2. Comparison of NF-kB expression in reporter mice treated with LPS alone or ethanol and LPS. A For the naive mouse,
luminescence was 1.627610
4 CCD camera counts. B In the group treated with LPS only, 2.406610
5 counts were measured for mouse one, 1.347610
5
counts for mouse two, and 8.485610
4 counts for mouse three. C In the group treated with LPS+86.8 mM EtOH, 4.754610
4 counts were measured for
mouse one, 3.213610
4 for mouse two, and 8.869610
4 for mouse three. D Mice treated with 6 g/kg ethanol before LPS showed significant reduction
of luminescence (*=LPS plus EtOH vs. LPS only: P,0.05).
doi:10.1371/journal.pone.0029890.g002
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activated with LPS or poly I:C
Tumor necrosis factor alpha converting enzyme (TACE/
ADAM17), a metalloprotease, is located in the cell membrane
and cleaves pro-TNF-a from the cell surface. TAPI-0 (TNF-a
processing inhibitor-0) is an inhibitor of metalloproteases. In this
experiment, the extent of TACE contribution to the level of TNF-
a shed into the cell culture supernatant was evaluated (Figure 4).
In the LPS experiment, RAW264.7 cells were treated with 10 ng/
ml LPS alone, LPS plus 25 mg/ml TAPI-0, LPS plus 5 ml DMSO
(control for the DMSO used to dissolve TAPI-0), or TAPI-0 alone.
In the poly I:C experiment, RAW264.7 cells were treated with
50 mg/ml poly I:C alone, 25 mg/ml TAPI-0 plus poly I:C,
86.8 mM EtOH plus poly I:C, TAPI-0 plus 86.8 mM EtOH plus
poly I:C, or 5 ml DMSO. In both experiments, naive untreated
cells served as control. TAPI-0 was dissolved in DMSO. A control
group was included to account for any inhibition of TNF-a caused
by DMSO. First, TNF-a secretion was compared between cells
treated with TAPI-0 plus LPS, LPS alone, or DMSO plus LPS
(Figure 4A). It was obvious, that DMSO itself caused a significant
decrease in TNF-a (LPS only vs. DMSO plus LPS: P,0.001).
However, when the groups TAPI-0 plus LPS and DMSO plus
LPS were compared, a highly significant decrease in TNF-a due to
TACE inhibition was seen (P,0.001). In the naive group and the
group treated only with TAPI-0, no TNF-a could be detected by
ELISA. Next, the effect of TAPI-0 on cells activated with poly I:C
was examined. Poly I:C alone and DMSO plus poly I:C were
compared to TAPI-0 plus poly I:C, 86.8 mM EtOH plus poly I:C,
or TAPI-0 plus 86.8 mM EtOH plus poly I:C. Naive, untreated
cells served as control (Figure 4B). Ethanol significantly inhibited
the poly I:C induced TNF-a response (P,0.001). Compared to
DMSO plus poly I:C, TAPI-0 significantly reduced TNF-a in the
cell culture supernatant (P,0.001). In the group treated with
EtOH before adding TAPI-0 and poly I:C, no TNF-a was
detected by ELISA. In the naive group, TNF-a level was below the
limit of detection. These results indicate that secreted TNF-a
measured by ELISA in cell culture supernatants is mainly, if not
entirely, due to cleavage by TACE.
Inhibition of TACE increases, and ethanol decreases, cell
surface expression of TNF-a in LPS treated macrophage-
like cells
The previous experiments suggest that ethanol decreases
signaling through NF-kB and TNF-a synthesis, and therefore it
should decrease surface TNF-a. If ethanol also decreases TACE
activation, an increase in surface TNF-alpha could be expected
because of a diminished rate of shedding. As an indirect approach
to evaluate the effect of ethanol on TACE activity, and to
quantitate surface TNF-a with and without ethanol, the expression
of surface TNF-a was measured by flow cytometry. TACE was
inhibited by TAPI-0 to examine the effect of ethanol on TNF-a
surface expression before shedding. For all flow cytometry
experiments, TAPI-0 was dissolved in RPMI to avoid the cytotoxic
effect of DMSO. As noted in Materials and Methods, DMSO was
used at the recommendation on the manufacturer, but at the
relatively low concentrations of TAPI-0 needed for this study, the
compound was soluble in an aqueous solution without DMSO.
The RAW264.7 cells were transferred into microcentrifuge tubes
Figure 3. Real time RT-PCR with mRNA isolated from RAW264.7
cells treated with ethanol and LPS or poly I:C. Naive groups
received no treatment. A Appropriate groups were treated with ethanol
for 30 min, then with LPS for further two hours. The average of two
experiments, each with three replicates, were pooled. Each sample
replicate was doubled in the PCR plate. 86.8 mM ethanol significantly
reduced the LPS induced TNF-a mRNA expression (P,0.001). Treatment
with ethanol only was not significantly different from naive. B
Appropriate groups were treated with different concentrations of
ethanol for 30 min, then with poly I:C for further two hours. The
average of two experiments, one with three replicates, and one with
two replicates, is shown. Each sample replicate was doubled in the PCR
plate. A concentration of 43.4 mM EtOH and higher significantly
reduced the poly I:C induced TNF-a mRNA expression (P,0.01). Ethanol
without poly I:C was not significantly different from naive. Results were
normalized to 18S and analyzed using the DDCt method. Bars with no
shared letters are significantly different (p,0.05).
doi:10.1371/journal.pone.0029890.g003
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6/ml. Appropriate groups were treated with 43.4 and
86.8 mM ethanol for 30 min, and then with 100 ng/ml LPS and/
or 20 mg/ml TAPI-0 for further 2 h. Supernatants were collected
and subjected to ELISA (Figure 5 B and D). Cells were labeled
with monoclonal rat anti mouse TNF-a FITC conjugate and flow
cytometry was performed (Figure 5A and C). Naive unlabeled cells
showed very low fluorescence. Labeling with isotype control was
performed with LPS treated cells in each experiment, and
fluorescence was similar to naive unlabeled cells (data not shown).
The results are shown as % gated (Figure 5A and C). The gate was
set to exclude ,99% of the cells in isotype or unlabeled controls
and to exclude forward scatter values indicating that cell clusters
rather than single cells were being assessed. Results for mean
fluorescence intensity were also calculated, but the pattern of
effects was very similar to that for % gated, so only the results for
% gated are shown here. In the LPS treated group, TNF-a surface
expression was significantly above naive (P,0.001 for % gated in
both experiments). Analysis by ELISA showed a significant
increase in TNF-a in the supernatant versus naive (P,0.001 in
both experiments). Whilst high surface expression of TNF-a
reflects an increase in gene transcription and/or decreased TACE
activity, high TNF-a in the cell culture supernatant is due to
TACE activity in the activated macrophage. Treatment with
86.8 mM ethanol significantly inhibited LPS induced TNF-a
surface expression versus LPS only in both experiments (P,0.001
for % gated). TNF-a in cell culture supernatants measured by
ELISA was decreased accordingly (P,0.001), reflecting a decrease
in TNF-a synthesis. A decrease in TACE activity could have
potentially contributed to a decreased TNF-a release by
macrophages. However, a decrease in surface TNF-a caused by
86.8 mM ethanol indicates that decreased TNF-a release is not
caused solely by a decrease in TACE activity, which would yield
an increase in surface TNF-a.
Ethanol decreases TNF-a secretion, but not TNF-a cell
surface expression in poly I:C treated macrophage-like
cells
The above described experiments were repeated with the TLR3
activator poly I:C. Inhibition of poly I:C induced TNF-a gene
expression by ethanol, as suggested by the real time RT-PCR
results, should be reflected by a decrease in TNF-a surface
expression similar to the results with LPS. The RAW264.7 cells
were treated and labeled as in the above experiments, with the
exception that 50 mg/ml poly I:C was used instead of LPS. The
fluorescence for naive unlabeled cells and isotype control with poly
I:C treated cells were similar and with a mean fluorescence
intensity less than 10 (data not shown). Two independent
experiments were conducted (experiment 1 shown in 6 A and B;
experiment 2 shown in 6 C and D). Surface TNF-a expression is
indicated as % gated (Figures 6 A and C). An ELISA was
performed from cell culture supernatants of the cells used for flow
cytometry (Figures 6 B and D). Similar to the previous
experiments, TACE inhibition caused a significant increase in
surface TNF-a in naive cells (P,0.001 for % gated both
experiments), and a significant decrease in TNF-a in the culture
supernatant (P,0.001 for both experiments). In contrast results
obtained with LPS, treatment with poly I:C did not cause a change
in the amount of surface TNF-a in either experiment. However, as
with LPS, the increase in secreted TNF-a detected by ELISA was
significant (P,0.001 vs. naive for both experiments). If TNF-a
surface expression is determined by rate of synthesis and insertion
of TNF-a minus the rate of cleavage by TACE, the results
reported here seem to indicate that increased TNF-a membrane
insertion in poly I:C treated cells is precisely balanced by increased
cleavage by TACE. As expected, TNF-a surface expression was
significantly higher in the poly I:C plus TAPI-0 group than in the
poly I:C only group (P,0.001 for % gated both experiments), and
TNF-a detection in the supernatants was significantly lower
(P,0.001 in both experiments). Treatment with 43.4 mM ethanol
before poly I:C did not change the amount of TNF-a surface
expression in either experiment, but it decreased TNF-a in cell
culture supernatants (P,0.01 for both experiments). Treatment
with 86.8 mM ethanol before poly I:C decreased TNF-a surface
expression only in the second experiment (P,0.01 for % gated),
but TNF-a in cell culture supernatants was significantly decreased
in both experiments (P,0.001). The effect of ethanol on total
TNF-a membrane insertion was revealed by inhibition of
Figure 4. Effect of TACE inhibition on the LPS and poly I:C
induced TNF-a response in RAW264.7 cells. TNF-a levels were
measured by ELISA from cell culture medium immediately after
collection. Each group contained 6 samples. Naive groups received
no treatment. A Cells were treated with 25 mg/ml TAPI-0, 5 ml/ml DMSO,
and/or 100 ng/ml LPS. Treatments were given at the same time point
and cells were incubated 2 h. B Appropriate groups were treated with
86.8 mM EtOH and incubated 30 min. Cells were treated with 25 mg/ml
TAPI-0, 5 ml DMSO, and/or 50 mg/ml poly I:C, and incubated further 2 h.
Bars with no shared letters are significantly different (p,0.05; nd=not
detectable).
doi:10.1371/journal.pone.0029890.g004
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e29890Figure 5. Surface expression of TNF-a on RAW264.7 cells measured by flow cytometry, and TNF-a ELISA from cell culture
supernatants of the same experiments. Results shown in A and B were obtained in one experiment and results shown in C and D were
obtained in an independent experiment. In some groups, no TNF-a was detected (nd). Each group contained 5 samples. Two repeat experiments are
shown. Cells were treated with ethanol (either 43.4 mM or 86.8 mM), 100 ng/ml LPS or 20 mg/ml TAPI-0, or a combination of these treatments. ELISA
was performed from cell culture supernatants of each group. The percentage of gated cells (positive for TNF-a surface expression by flow cytometry)
for each group is shown in A & C. The ELISA results from cell culture supernatants of the cells used for flow cytometry are depicted in B and D. Bars
designated by the same letter are not significantly different (p.0.05); bars with no shared letters are significantly different (p,0.05). Histograms for
representative samples from key groups for the experiment shown in A are shown below panels C and D.
doi:10.1371/journal.pone.0029890.g005
Mechanism of Inhibited TNF-a Secretion by Ethanol
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e29890shedding. Groups treated with 43.4 mM or 86.8 mM ethanol
before poly I:C and TAPI-0 showed a significant decrease in
surface TNF-a versus poly I:C plus TAPI-0 (P,0.001 for %
gated). It seems likely that this was due to a decrease in TNF-a
production, because TAPI-0 almost completely blocked release of
TNF-a, thus almost completely inhibited TACE. This left only
alterning TNF-a production and eliminated alteration of TACE
activity as the mechanism of this action of ethanol.
Discussion
It has been widely accepted that excessive ethanol consumption
increases susceptibility to infections, especially pneumonia.
However, the mechanisms underlying the effects of alcohol on
host defense are not fully understood. Studies in mouse models
show that TNF-a plays a key role in host defense [29], [30], [31].
The mechanism of action of ethanol on TLR4 (LPS)-induced
macrophage responses (including TNF-alpha production) is very
similar in human and mouse cells [32].
A major reason for conducting this study were reports
indicating that TNF-alpha production was inhibited by ethanol
primarily at the post-transcriptional level [6,7]. Our previous
studies indicated inhibition at the level of transcription [2], but
we had not previously evaluated the role of TACE and whether it
could be a major molecular target of ethanol. In the study
described here, we investigated whether the inhibition of LPS- or
poly I:C-induced TNF-a production by concentrations of ethanol
relevant in human binge drinking reflects inhibition of transcrip-
tion or post-transcriptional events. The results support an
important role for decreased transcription, but not for decreased
TACE activity in the inhibition of TNF-alpha production by
ethanol.
Figure 6. Surface expression of TNF-a in RAW264.7 cells measured by flow cytometry, and TNF-a ELISA from cell culture
supernatants of the same experiments. Results shown in A and B were from one experiment and results shown in C and D are from an
independent experiment. Each group contained 5 samples. Cells were treated with ethanol (either 43.4 mM or 86.8 mM, as indicated in the Figure),
50 mg/ml poly I:C, 20 mg/ml TAPI-0 (with no DMSO), or a combination of these treatments. ELISA was performed from cell culture supernatants of
each group. The percentage of gated cells for each group is shown in A and C. Results for TNF-a ELISA from cell culture supernatants of the cells used
for flow cytometry are depicted in B and D. Values for bars designated by the same letter are not significantly different (p.0.05); values for bars with
no shared letters are significantly different (p,0.05).
doi:10.1371/journal.pone.0029890.g006
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of a human and a murine cell line (Mono Mac 6 and DRM)
decreased activation of TACE and release of TNF-a. Our results
did not seem to fully coincide with theirs, but it should be noted
that it remains possible that there was a decrease in TACE activity
caused by ethanol in our experimental system, even though the
evidence as a whole indicates inhibition of TACE function is not
the major mechanism of ethanol action. These investigators also
did not find decreased expression of TNF-a mRNA, suggesting
that the overall experimental system differs from ours, possibly
because of differences among the cell lines used.
To better understand the dynamics of TNF-a production and
release of the soluble form of TNF-a, we inhibited protein
synthesis with cycloheximide after challenge with TLR ligand. It
was shown that TNF-a is primarily synthesized de novo after
activation with LPS or poly I:C. Even though the cycloheximide
experiment does not exclude that TNF-a protein is stored in the
cells (in excess of the small amount found in the membrane), it is
unlikely, because TNF-a synthesis was abrogated even when
protein synthesis was inhibited 30 min after TLR activation.
Ethanol has been shown by western blot and electrophoretic
mobility shift assay (EMSA) to inhibit LPS induced NF-kB
activation in human monocytes [33]. In an experiment with NF-
kB reporter mice we tested, if ethanol inhibition of LPS induced
TNF-a secretion starts at the signaling pathway, and if total NF-
kB activation in vivo was inhibited by ethanol. Through in vivo
imaging of NF-kB activity, we could show, that ethanol
significantly inhibited LPS-induced activation of NF-kB induced
gene transcription. This is consistent with our previous studies
indicating that ethanol inhibits TNF-a production in response to
LPS by inhibiting the formation of a fully functional TLR4
receptor complex and inhibiting TLR4-induced signaling at early,
intermediate, and late (NF-kB) stages [34], [35]. However, it is
unclear whether most of the NF-kB activation in this system was
mediated by the primary stimulus (LPS or poly I:C), or by a
secondary stimulus (such as TNF-a). In addition, it would be useful
to know, in which organs and cell types ethanol suppresses NF-kB
activation. It is known that Kupffer cells of the liver represent the
largest concentration of macrophages in any single anatomical
location, and it is noted, that this region is among the most
inhibited by ethanol. Additional evidence would be needed to
confirm, that the liver is a major location of cytokine production
and that it is inhibited by ethanol.
In real time RT-PCR studies we evaluated if NF-kB inhibition
by ethanol leads to a decrease in TNF-a mRNA. We found that
the upregulation of TNF-a mRNA by LPS and poly I:C was
consistently decreased by ethanol. This is consistent with our
recent results indicating suppression by ethanol of TLR signaling
and the production of a wide range of inflammation-related
cytokines and chemokines [1], [5].
TACE releases TNF-a from the cell surface by shedding [14].
To evaluate if secretion of TNF-a is entirely dependent on TACE
in cells activated with LPS or poly I:C, we used the metallopro-
tease inhibitor TAPI-0. Our results show that TNF-a secretion is
almost completely abrogated if TACE is inhibited. This indicates,
that shedding through TACE is required for release of the vast
majority of TNF-a from the cells used in these studies. The
metalloprotease inhibitor TAPI-0 is widely used to study protein
shedding from the cell surface. In studies reviewed, the solvent for
TAPI-0 was not mentioned, and there was no description of
vehicle controls, e.g. [36], [37]. According to the manufacturer’s
instructions, TAPI-0 can be reconstituted in DMSO, EtOH, and
10% acetyl hydroxide in EtOH. To decrease the cytotoxic effect of
DMSO, we used only 10% of the recommended volume, resulting
in a final concentration of 0.5% in cell culture. Even at this
concentration, we saw a significant decrease in ELISA detection of
TNF-a, and a decrease in TNF-a cell surface expression in flow
cytometry due to DMSO alone. Even at a concentration of
0.005%, DMSO significantly inhibited cell surface expression of
TNF-a measured by flow cytometry (data not shown). In an in
vivo study with rats it has been observed, that using DMSO as a
vehicle for a drug may exert effects due to DMSO alone [38].
Therefore, we used TAPI-0 in a solution in RPMI for further
experiments.
We showed by flow cytometry that treatment with LPS, but
not treatment with poly I:C significantly increased cell surface
TNF-a. Corresponding ELISA, however, showed increased free
TNF-a after treatment with both, LPS and poly I:C, possibly due
to an increase in TACE activity as well as upregulation of
production of TNF-a. An upregulation of TACE mRNA with a
peak after 2 h, and increased TACE surface expression measured
by flow cytometry in human alveolar macrophages by LPS and
IFN-c after 20 h was reported by Armstrong et al. This LPS-
induced TACE expression was found to be downregulated by IL-
10 [39]. Our results show that poly I:C does not increase TNF-a
synthesis to the same extent as LPS (Figure 3). Consequently,
TACE activity may be sufficient to prevent the increase in surface
TNF-a in poly I:C-treated cells. Inhibition of TACE by TAPI-0
increased surface TNF-a in both LPS and poly I:C treated cells as
well as in naive cells through inhibition of shedding. It has been
suggested that ethanol decreases TNF-a by inhibition of TACE
[40], [31], or by physically preventing protein –protein
interaction between TNF-a and TACE [41]. If ethanol acts
primarily as a TACE inhibitor, we would expect surface TNF-a
to be increased (as shown in cells treated with TAPI-0 in Figures 5
and 6). Possible explanations for the inconsistency between our
results and those of another group are discussed in a previous
paragraph.
Our results indicate that inhibition of NF-kB signaling and
decreased TNF-a mRNA expression by ethanol occurred and
acted to decrease surface TNF-a. The ethanol effect on TNF-a
surface expression was more prominent in LPS treated cells. The
free TNF-a in corresponding cell culture supernatants was
significantly decreased by 43.4 mM ethanol in both LPS and
poly I:C treated cells, which may be partly due to some inhibition
of TACE activity. The effect of ethanol on TNF-a surface
expression in the absence (or near absence) of TACE activity was
revealed when shedding was inhibited by TAPI-0. In LPS and
poly I:C treated cells. Ethanol at only 43.4 mM significantly
decreased TNF-a surface expression, supporting the PCR results
showing decreased TNF-a synthesis. Although we cannot exclude
TACE inhibition caused by ethanol, our results indicate that
decreased TNF-a production has more effect than any decrease in
TACE activity that ethanol may cause.
Taken together, in this study we have shown, that new
protein synthesis is required for maximum production of
secreted TNF-a,a n dt h a tT N F - a is not stored in the cell in a
form ready for secretion. Our results indicate that inhibition of
LPS- or poly I:C-induced TNF-a production by ethanol starts at
the signaling pathway and is not limited to post-transcriptional
effects (such as cleavage by TACE). Decreased transcription, not
just TACE inhibition, is involved in decreased TNF-a
production, as indicated by comparing the changes of surface
a n ds e c r e t e dT N F - a in ethanol and TAPI-0 treated cultures.
The above findings give new insights into the mechanisms of
ethanol inhibition of TLR signaling. However, it is possible, that
ethanol interferes with other proteins in the TLR signaling
cascade.
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Cell culture assays
The RAW264.7 macrophage like cell line was purchased from
American Type Culture Collection (ATCC). The RAW264.7 cells
were cultured in RPMI 1640 with L-glutamine (# 61870-036,
Invitrogen, Carlsbad, CA, USA) supplemented with 10% FBS (#
10437-028, Invitrogen) and penicillin-streptomycin (# P4333,
Sigma-Aldrich, Saint Louis, MO, USA). They were used before
the 10th passage. Cells were grown in 75 cm
2 tissue culture flasks
(Sarstedt INC, Newton, NC 28658-0468, USA) at 37u C and 5%
CO2.
Poly I:C (# tlrl-pic-5) was purchased from Invivogen (San
Diego, CA). Ultra Pure lipopolysaccharide (LPS) from E. coli
serotype O111:B4 was obtained from List Biological Laboratories
(# 421, List Biological Laboratories, INC., Campbell, CA, USA).
The protein synthesis inhibitor cycloheximide was purchased from
Sigma Aldrich (# C1988, Sigma Aldrich, St. Louis, MO). The
TACE inhibitor TAPI-0 was purchased from Peptides Interna-
tional (# INH-3850-PI, Peptides International, Inc., Louisville,
KY, USA). For all cell culture assays, cells were seeded into
NUNC 24-well plates (# 142475, Thermo Fisher, Rochester, NY,
USA) at 1610
6/ml, 1 ml/well, and grown for 24 h before the
experiment. Appropriate wells were treated with 86.8 mM ethanol
and incubated 30 min. Then, 100 ng/ml LPS or 50 mg/ml poly
I:C were added to appropriate wells, and incubated further 2 h.
Supernatants were collected or cells harvested for further
procedures that were performed within 30 min after harvesting.
For the protein synthesis inhibitor experiment, cells were cultured
as described above, and appropriate wells (6 samples per group)
were treated with 5 mg/ml cycloheximide.
Quantitation of cytokines in cell culture supernatants by
ELISA
A mouse cytokine ELISA kit was obtained from BD Biosciences
(San Jose, CA, USA; BD OptEIA Mouse TNF-a Mono/Mono #
555268). The assay was carried out according to the manufactur-
er’s specifications. NUNC maxisorp 96 well ELISA plates were
used (# 439454, Thermo Fisher, Rochester, NY, USA).
NF-kB reporter mice
Transgenic mice of C57BL/6J X CBA/J genetic background
carrying the luciferase gene driven by an NF- kB response
element, as described by Carlsen et al. [42], were obtained from
Xenogen (Alameda, CA). D-Luciferin was purchased from Caliper
(# 122796, Hopkinton, MA, USA). Mice were treated with
ethanol by gavage at 6 g/kg as a 32% solution in water 5 min
before NF-kB activation. LPS was administered via tail vein
injection at 60 mg per mouse. One and a half hr later, mice were
anesthetized with isoflurane by inhalation, and 150 mg/kg
luciferin was injected intraperitoneally. Mice were oriented
similarly and the ventral surface was imaged for all mice. Imaging
was performed 5–10 min later with an IVIS imager (Xenogen,
Alameda, CA). Mice were maintained and used in accord with the
NIH Guide for Care and Use of Animals and the Guidelines of
Mississippi State University. The animal care system at Mississippi
State University is accredited by the American Association for
Accreditation of Laboratory Animal Care, and the work described
here adhered to the guidelines of that organization as well. The
work was approved by the Mississippi State University Animal
Care and Use Committee and animal care (protocol #07-066) was
supervised by Dr. Lucy Senter, a board certified Laboratory
Animal Veterinarian.
Real time RT-PCR
Samples of RAW264.7 cells were lysed, RNA was purified with
the RNeasy Plus Mini Kit 50 (# 74134, Qiagen, Valencia, CA).
Cell lysates were homogenized with QiaShredders (# 79654,
Qiagen). Samples were prepared with the SuperScript III
Platinum SYBR Green One-Step qRT-PCR Kit with ROX
reference dye (#11746-100, Invitrogen, Carsbad, CA). Real time
RT-PCR was performed with the Stratagene Mx3005P QPCR
System (Agilent Technologies, Cedar Creek, TX). Primers were
designed with the Roche primer design software (Universal Probe
Library, Primer 3 settings, Roche Applied Sciences, Indianapolis,
IN, USA).
Mouse TNF-a:
forward: 59-TGCCTATGTCTCAGCCTCTTC-39
reverse: 59-GAGGCCATTTGGGAACTTCT-39
Mouse 18S:
forward: 59-AAATCAGTTATGGTTCCTTTGGTC-39
reverse: 59-GCTCTAGAATTACCACAGTTATCCAA-39
All samples were normalized to 18S. Data were analyzed using
the DDCt method.
TACE inhibitor experiment
Cultures of RAW264.7 cells were treated with ethanol, LPS or
poly I:C as described above. In the initial experiments with TACE
inhibition, 1 mg TAPI-0 was reconstituted in 20 ml DMSO to a
final concentration of 5 mg/ml, as recommended. Appropriate
wells were treated with 25 mg/ml TAPI-0 or 5 ml/ml DMSO right
before addition of LPS or poly I:C. Supernatants were harvested
and further analyzed by mouse TNF-a ELISA. In later
experiments, TAPI-0 was dissolved directly in complete medium
to double the final concentration needed and added to each
culture to dilute it to the final concentration, 20 mg/ml.
Analysis of cell surface TNF-a by flow cytometry
FACS buffer at pH 7.2–7.4 was prepared with sterile phosphate
buffered saline (Sigma Chemical Co., St. Louis, MO), 0.5%
sodium azide, and 2% fetal bovine serum. In some cultures TAPI-
0 was added, as noted above. The RAW264.7 cells were grown in
75 cm
2 tissue culture flasks and transferred into sterile, endotoxin
free Eppendorf tubes at 2.5610
6/ml. Appropriate tubes were
treated with 86.8 mM EtOH for 30 min, and with 20 mg/ml
TAPI-0, 100 ng/ml LPS, or 50 mg/ml poly I:C for another 2 h.
The caps were left open and loosely covered with sterile lids to
ensure air supply to the cells. Then, cells were pelleted at
1500 rpm at 4uC for 4 min and re-suspended in 200 ml FACS
buffer. Cells were then transferred into a 96 well V-bottom plate,
pelleted and resuspended in 200 ml FACS buffer. Appropriate
wells were labeled with 1 ml fluorochrome conjugated primary
antibody and incubated for 20 min on ice. Antibodies were
obtained from Invitrogen: Monoclonal rat anti mouse TNF-a
FITC conjugate (# RM9011), and rat IgG FITC isotype control
(# R101). Samples were washed twice and resuspended in 200 ml
FACS buffer after final wash. Experiments were carried out on a
BD FACS Calibur flow cytometry system (BD Biosciences, San
Jose, CA, USA).
Statistical analysis
Real time RT-PCR results were analyzed with the delta delta
CT method, using Microsoft Excel 2004 for Mac, version 11.0
(Microsoft Corporation, Redmond, Wa, USA). For the NF-kB
reporter study, the unpaired t-test was used to compare the LPS-
treated group and the group treated with LPS plus ethanol.
Although one untreated control animal was included, this was not
Mechanism of Inhibited TNF-a Secretion by Ethanol
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confirm that the instrument settings were appropriate and were
not yielding substantial emissions in the absence of treatment. For
all experiments with more than two groups, results were analyzed
by one way analysis of variance with the Newman-Keuls multiple
comparison test to compare the significance of the difference of
each mean value to every other mean value. A P value,0.05 was
considered significant. Prism 4.0 software (GraphPad Software,
INC, La Jolla, CA, USA) was used for analysis.
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